Drug Response Dx Overview

  • Founded
  • 2012
Founded
  • Status
  • Private
  • Latest Deal Type
  • 2ndary - Private

Drug Response Dx General Information

Description

Manufacturer of biomarker test intended to assess treatment results for rheumatoid arthritis. The company's tests are based on a protein that helps to predict the individual effectiveness of TNF-alpha inhibitors for each patient before medication is given, enabling patients to begin treatment quickly and result in a high likelihood of successful treatment.

Contact Information

Website
www.drdx.de
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Primary Office
  • Neuendorfstraße 17
  • 16761 Hennigsdorf
  • Germany
+49 03302 0000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Drug Response Dx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Secondary Transaction - Private 01-Apr-2021 Completed Generating Revenue
1. Early Stage VC 07-Jan-2013 Completed Generating Revenue
To view Drug Response Dx’s complete valuation and funding history, request access »

Drug Response Dx Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Manufacturer of biomarker test intended to assess treatment results for rheumatoid arthritis. The company's tests are ba
Diagnostic Equipment
Hennigsdorf, Germany
00000000000

00000000

fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia des
0000 000000000
New York, NY
00 As of 0000
0000
00.00 0000-00-00
00000000000 0000

000 0000

it esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt
0000 000000000
Barcelona, Spain
00 As of 0000
0000
00000000000 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Drug Response Dx Competitors (2)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Volastra Venture Capital-Backed New York, NY 00 0000 00000000000 0000
000 000000000000 Venture Capital-Backed Barcelona, Spain 00 0000 00000000000 0000
You’re viewing 2 of 2 competitors. Get the full list »

Drug Response Dx Executive Team (5)

Name Title Board Seat Contact Info
Jörg-M Hollidt Ph.D Managing Director & Co-Founder
Karl Skriner Co-Founder
You’re viewing 2 of 5 executive team members. Get the full list »

Ready to get started?

Request a free trial